Value of Hematological Parameters in Predicting Major Adverse Cardiovascular Events after PCI in Patients with Acute STEMI
Department of Emergency Medicine,First Affiliated Hospital,School of Medicine,Shihezi University,Shihezi 832002,China
*Corresponding author:LI Guihua,Chief physician;E-mail:lgh169@126.com
CHEN Xinsen,SHAO Meng,ZHANG Tian, et al. Value of Hematological Parameters in Predicting Major Adverse Cardiovascular Events after PCI in Patients with Acute STEMI [J]. Chinese General Practice, 2020, 23(27): 3389-3395. DOI: 10.12114/j.issn.1007-9572.2020.00.245.
陈鑫森,邵萌,张天等. 血液学参数预测急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术后发生主要不良心血管事件的价值研究[J]. 中国全科医学, 2020, 23(27): 3389-3395. DOI: 10.12114/j.issn.1007-9572.2020.00.245.
[1]?INAR T,?AGDAS M,RENCUZOGULLARI I,et al.Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction[J].Scand Cardiovasc J,2019,53(2):83-90.DOI:10.1080/14017431.2019.1590628.
[2]ZHANG H Y,QIU B H,ZHANG Y,et al.The value of pre-infarction angina and plasma D-dimer in predicting no-reflow after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction patients[J].Med Sci Monit,2018,24:4528-4535.DOI:10.12659/MSM.909360.
[3]KLINGENBERG R,AGHLMANDI S,R?BER L,et al.Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT,NT-proBNP and hsCRP with the GRACE score[J].Eur Heart J Acute Cardiovasc Care,2018,7(2):129-138.DOI:10.1177/2048872616684678.
[4]MORIYA J.Critical roles of inflammation in atherosclerosis[J].J Cardiol,2019,73(1):22-27.DOI:10.1016/j.jjcc.2018.05.010.
[5]FAN Z,LI Y,JI H,et al.Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention:a retrospective cohort study[J].BMJ Open,2018,8(10):e023459.DOI:10.1136/bmjopen-2018-023459.
[6]KURTUL A,ACIKGOZ S K.Usefulness of mean platelet volume-to-lymphocyte ratio for predicting angiographic no-reflow and short-term prognosis after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction[J].Am J Cardiol,2017,120(4):534-541.DOI:10.1016/j.amjcard.2017.05.020.
[7]WAGDY S,SOBHY M,LOUTFI M.Neutrophil/lymphocyte ratio as a predictor of in-hospital major adverse cardiac events,new-onset atrial fibrillation,and no-reflow phenomenon in patients with ST elevation myocardial infarction[J].Clin Med Insights Cardiol,2016,10:19-22.DOI:10.4137/CMC.S35555.
[8]BRESSI E,MANGIACAPRA F,RICOTTINI E,et al.Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-year clinical outcomes of patients with stable coronary artery disease undergoing elective percutaneous coronary intervention[J].J Cardiovasc Transl Res,2018,11(6):517-523.DOI:10.1007/s12265-018-9829-6.
[9]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.DOI:10.3760/cma.j.issn.0253-3758.2015.05.003.
[10]李艳秋,陈广生,马德渊,等.平均血小板体积与血小板计数比值对急性ST段抬高性心肌梗死患者行PCI预后的预测价值[J].中国急救医学,2019,39(5):412-415.DOI:10.3969/j.issn.1002-1949.2019.05.003.
[11]JIAO Q B,KE Q,LI W W,et al.Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction[J].Clin Exp Pharmacol Physiol,2015,42(2):162-170.DOI:10.1111/1440-1681.12339.
[12]ZHANG S M,WAN Z F,ZHANG Y,et al.Neutrophil count improves the GRACE risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction[J].Atherosclerosis,2015,241(2):723-728.DOI:10.1016/j.atherosclerosis.2015.06.035.
[13]MACHADO G P,ARAUJO G N,CARPES C K,et al.Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction[J].Atherosclerosis,2018,274:212-217.DOI:10.1016/j.atherosclerosis.2018.05.022.
[14]GONZáLEZ-PACHECO H,BOJALIL R,AMEZCUA-GUERRA L M,et al.Derivation and validation of a simple inflammation-based risk score system for predicting in-hospital mortality in acute coronary syndrome patients[J].J Cardiol,2019,73(5):416-424.DOI:10.1016/j.jjcc.2018.11.010.
[15]ZHANG S,DIAO J,QI C M,et al.Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention:a meta-analysis[J].BMC Cardiovasc Disord,2018,18(1):75.DOI:10.1186/s12872-018-0812-6.
[16]BOLAT I,AKGUL O,CAKMAK H A,et al.The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Kardiol Pol,2016,74(4):346-355.DOI:10.5603/KP.a2015.0179.
[17]PARK J S,SEO K W,CHOI B J,et al.Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction[J].Medicine(Baltimore),2018,97(48):e13471.DOI:10.1097/MD.0000000000013471.
[18]SOEHNLEIN O.Multiple roles for neutrophils in atherosclerosis[J].Circ Res,2012,110(6):875-888.DOI:10.1161/CIRCRESAHA.111.257535.
[19]FREDMAN G,TABAS I.Boosting inflammation resolution in atherosclerosis:the next frontier for therapy[J].Am J Pathol,2017,187(6):1211-1221.DOI:10.1016/j.ajpath.2017.01.018.
[20]HER A Y,CHO K I,SINGH G B,et al.Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction[J].Int J Cardiovasc Imaging,2017,33(10):1445-1454.DOI:10.1007/s10554-017-1135-x.
[21]LEY K,MILLER Y I,HEDRICK C C.Monocyte and macrophage dynamics during atherogenesis[J].Arterioscler Thromb Vasc Biol,2011,31(7):1506-1516.DOI:10.1161/ATVBAHA.110.221127.
[22]WEINSTOCK A,FISHER E A.Methods to study monocyte and macrophage trafficking in atherosclerosis progression and resolution[J].Methods Mol Biol,2019,1951:153-165.DOI:10.1007/978-1-4939-9130-3_12.
[23]KIRIS T,?ELIK A,VARIS E,et al.Association of lymphocyte-to-monocyte ratio with the mortality in patients with ST-elevation myocardial infarction who underwent primary percutaneous coronary intervention[J].Angiology,2017,68(8):707-715.DOI:10.1177/0003319716685480.
[24]KILIC A,KURTUL A.RETRACTED:mean platelet volume-to-lymphocyte ratio as a novel marker for severity and complexity of coronary atherosclerosis in patients with acute coronary syndrome[J].Angiology,2017:3319717724274.DOI:10.1177/0003319717724274.
[25]XU N,TANG X F,YAO Y,et al.Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction[J].Catheter Cardiovasc Interv,2018,91(S1):551-557.DOI:10.1002/ccd.27495.
[26]CHOI D H,KOBAYASHI Y,NISHI T,et al.Combination of mean platelet volume and neutrophil to lymphocyte ratio predicts long-term major adverse cardiovascular events after percutaneous coronary intervention[J].Angiology,2019,70(4):345-351.DOI:10.1177/0003319718768658.